Cdmo News

Pharma API and CRAMS firms experienced a significant acceleration in profit after tax (PAT) growth during Q1 FY27, with the median rising to 47% from 8% in the

Dr. Reddy's CDMO arm, Aurigene, has secured a long-term manufacturing agreement with a major global pharmaceutical company. This initial portfolio includes over

Navin Fluorine's earnings momentum is accelerating due to new R32 refrigerant capacity and a growing CDMO business, offering fresh growth opportunities. However

Aarti Pharmalabs shares have surged over 33% in two days following strong Q1 results, which showed a 65.4% year-on-year profit increase and 38.7% revenue growth

Gland Pharma reported a 47% surge in its Q1 net profit to ₹317 crore, driven by higher revenue from recent product launches in its CDMO portfolio and strong cus

Nandini Piramal states that Piramal Pharma will prioritize policy actions over tariff tweets, leveraging its global manufacturing network and focusing on expand

Naturis Cosmetics, a contract development and manufacturing organization in the beauty & personal care sector, has successfully raised Rs 100 crore in its first